205 related articles for article (PubMed ID: 29982796)
1. Prostaglandin E2 receptor EP2 mediates the effect of cyclooxygenase 2 on secondary parathyroid hyperplasia in end-stage renal disease.
Zhang Q; Li S; Ye G; Wang M; Ni L; Kan S; Zhang M; Chen J
Nephrol Dial Transplant; 2019 Apr; 34(4):606-617. PubMed ID: 29982796
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.
Zhang Q; Qiu J; Li H; Lu Y; Wang X; Yang J; Wang S; Zhang L; Gu Y; Hao CM; Chen J
J Am Soc Nephrol; 2011 Apr; 22(4):664-72. PubMed ID: 21335517
[TBL] [Abstract][Full Text] [Related]
3. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
Cells; 2020 May; 9(5):. PubMed ID: 32438662
[TBL] [Abstract][Full Text] [Related]
4. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
5. AH6809 decreases production of inflammatory mediators by PGE
Li P; Jiang H; Wu H; Wu D; Li H; Yu J; Lai J
Brain Res; 2018 Nov; 1698():11-28. PubMed ID: 29792868
[TBL] [Abstract][Full Text] [Related]
6. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
[TBL] [Abstract][Full Text] [Related]
7. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
Kan S; Zhang W; Mao J; Wang M; Ni L; Zhang M; Zhang Q; Chen J
J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
[TBL] [Abstract][Full Text] [Related]
8. Role of the prostaglandin E2/E-prostanoid 2 receptor signalling pathway in TGFβ-induced mice mesangial cell damage.
Li NN; Xu YY; Chen XL; Fan YP; Wu JH
Biosci Rep; 2014 Dec; 34(6):e00159. PubMed ID: 25327961
[TBL] [Abstract][Full Text] [Related]
9. EP2/4 Receptors Promote the Synthesis of PGE
Zhang C; Wang L; Li T; Mao W; Liu B; Cao J
J Pharmacol Exp Ther; 2020 Feb; 372(2):175-184. PubMed ID: 31732699
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney.
Srivastava T; Alon US; Cudmore PA; Tarakji B; Kats A; Garola RE; Duncan RS; McCarthy ET; Sharma R; Johnson ML; Bonewald LF; El-Meanawy A; Savin VJ; Sharma M
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1323-33. PubMed ID: 25234310
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 derived PGE2 and PGI2 play an important role via EP2 and PPARdelta receptors in early steps of oil induced decidualization in mice.
Pakrasi PL; Jain AK
Placenta; 2008 Jun; 29(6):523-30. PubMed ID: 18407349
[TBL] [Abstract][Full Text] [Related]
14. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease.
Machado-Carvalho L; Martín M; Torres R; Gabasa M; Alobid I; Mullol J; Pujols L; Roca-Ferrer J; Picado C
J Allergy Clin Immunol; 2016 Jan; 137(1):99-107.e7. PubMed ID: 26560040
[TBL] [Abstract][Full Text] [Related]
15. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
Shiizaki K; Hatamura I; Negi S; Sakaguchi T; Saji F; Kunimoto K; Okamoto M; Imazeki I; Muragaki Y; Akizawa T
Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats.
Miyakogawa T; Kanai G; Tatsumi R; Takahashi H; Sawada K; Kakuta T; Fukagawa M
Clin Exp Nephrol; 2017 Aug; 21(4):563-572. PubMed ID: 27757708
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
Martins P; Schmitt F; Almeida H; Frazão JM
Nephrol Dial Transplant; 2008 Sep; 23(9):2889-94. PubMed ID: 18398016
[TBL] [Abstract][Full Text] [Related]
18. Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells.
Shiizaki K; Negi S; Hatamura I; Tatsuta K; Shibata M; Shimada S; Sakaguchi T; Akizawa T
Kidney Int Suppl; 2006 Jul; (102):S12-5. PubMed ID: 16810304
[TBL] [Abstract][Full Text] [Related]
19. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
Millanta F; Asproni P; Canale A; Citi S; Poli A
Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
Kang X; Qiu J; Li Q; Bell KA; Du Y; Jung DW; Lee JY; Hao J; Jiang J
Sci Rep; 2017 Aug; 7(1):9459. PubMed ID: 28842681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
